NewGenIvf (NIVF) Enterprise Value (2022 - 2025)

NewGenIvf has disclosed Enterprise Value across 4 years of filings, most recently posting -$1.4 million for Q4 2025.

• In Q4 2025, Enterprise Value rose 23.93% year-over-year to -$1.4 million; the TTM figure through Dec 2025 stood at -$1.4 million (up 23.93% YoY), while the FY2025 annual figure was -$1.4 million, up 23.93% from the prior year.
• Enterprise Value improved to -$1.4 million in Q4 2025, from -$3606.1 billion in the prior quarter.
• Over the last five years, Enterprise Value for NIVF reached as high as -$489986.0 in Q4 2022 and fell as low as -$3606.1 billion in Q3 2025.
• The 4-year median for Enterprise Value is -$1.7 million (2024), against an average of -$601.0 billion.
• Annual changes were most pronounced in 2024 — Enterprise Value tumbled 247.49% — and 2025, when it advanced 23.93%.
• A 4-year view of Enterprise Value shows it stood at -$489986.0 in 2022, then slipped by 11.06% to -$544155.0 in 2023, then plunged by 247.49% to -$1.9 million in 2024, then grew by 23.93% to -$1.4 million in 2025.
• According to Business Quant data, Enterprise Value over the past three periods registered -$1.4 million, -$3606.1 billion, and -$2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.